FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, particularly to a method of inhibiting apoptosis in mammalian cells. Said method involves incubation of cell cultures for 3 hours at 37 °C and 5% of CO2 in the presence in the culture medium of at least one peptide modulator capable of binding to voltage-dependent sodium ion channels and inhibiting their action, wherein peptide modulator used is toxins-knottins from venom of arthropods, molluscs and other poisonous animals.
EFFECT: invention provides changing the concentration of sodium ions in mammalian cells and reducing mass death of cells as a result of apoptosis.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT WITH ANTIAPOPTOTIC ACTIVITY | 2018 |
|
RU2685428C1 |
| APPLICATION OF PEPTIDE COMPOUND FOR APOPTOSIS INDUCTION IN A TUMOR CELL | 2022 |
|
RU2796104C1 |
| PEPTIDE COMPOUNDS FOR INDUCTION OF APOPTOSIS IN TUMOR CELL | 2021 |
|
RU2785794C2 |
| METHOD OF INDUCING APOPTOSIS OF MALIGNANT TUMOUR CELLS OF COLORECTAL CANCER AND MEANS FOR ITS REALISATION | 2013 |
|
RU2551238C9 |
| AGENT AND METHOD FOR APOPTOSIS INDUCTION IN CANCER CELLS | 2012 |
|
RU2488408C1 |
| PEPTIDE POSSESSING APOPTOTIC ACTIVITY WITH RESPECT TO HUMAN CANCER CELLS | 2006 |
|
RU2317304C1 |
| KINASES sgk 2 AND sgk 3 AS THE TARGETS FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES | 2001 |
|
RU2310471C2 |
| AGENT POSSESSING APOPTOSIS-INHIBITING ACTIVITY | 2018 |
|
RU2677877C1 |
| ANTITUMOR AGENTS BASED ON MACRO- AND MICROELEMENT-CONTAINING POLYGALACTURONATES (OPTIONS) | 2022 |
|
RU2792613C1 |
| METHOD OF PREPARING SKIN CELL MATRIX | 2008 |
|
RU2391399C2 |
